New eye drop combo aims to soothe dry eye sufferers
NCT ID NCT07412860
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new eye drop (FBV_01) that combines an extra ingredient with hyaluronic acid for people with moderate-to-severe dry eye. About 74 adults will use the drop four times a day for 30 days. Researchers will compare it to hyaluronic acid alone to see if the combo is better at relieving symptoms and is safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
eye drop containing an ancillary medicinal substance and hyaluronic acid 0.3% (FBV_01)
What this could lead to
If it works, this could offer a more effective eye drop for people with moderate-to-severe dry eye, improving comfort and reducing symptoms.
What could go wrong
This is a small, early-stage trial with only 74 participants. The improvement over existing drops may be small, and the open-label design could bias results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
S.C. di Oculistica Azienda Ospedaliero-Universitaria di Cagliari Presidio San Giovanni di Dio
RECRUITINGCagliari, CA, 09124, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
U.O. Oculistica Azienda Ospedaliero-Universitaria Renato Dulbecco
RECRUITINGCatanzaro, CZ, 88100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact